A mother in Bay City is on a mission to create more inclusivity and awareness for those with special needs.  This is to honor ...

Families in Connecticut and beyond are looking for answers when it comes to treating Angelman Syndrome, but fear funding ...

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

Continuing to grieve their loss, Blair's family decided to donate her brain to an American research facility to understand ...

Angelman syndrome is caused by several genetic mutations ... gene to increase the production of the UBE3A protein in the brain. In HALOS, three doses of ION582 were tested in 51 subjects ...

Angelman syndrome is caused by a large deletion of the region of the maternal chromosome that contains UBE3A, or by a DNA sequence change (mutation) in the UBE3A gene inherited from the mother.

In 1965, Dr. Harry Angelman was the first to report the symptoms of Angelman syndrome. The disorder occurs in approximately one in 15,000 births, and the syndrome is characterized by developmental ...

This is a five-month-old baby girl diagnosed with Angelman Syndrome. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...

The goal of this postdoctoral training program is to train young scientists and promote careers focused on understanding and developing treatments for developmental brain disorders ... but not limited ...